344 related articles for article (PubMed ID: 6980699)
1. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
2. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
Das SN; Khanna NN; Khanna S
Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
[TBL] [Abstract][Full Text] [Related]
3. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.
Wanebo HJ; Rosen PP; Thaler T; Urban JA; Oettgen HF
Ann Surg; 1976 Sep; 184(3):258-67. PubMed ID: 962394
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
Das SN; Khanna NN; Khanna S
Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
[TBL] [Abstract][Full Text] [Related]
6. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
7. [The immune competence of patients with Crohn's disease (author's transl)].
Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
[TBL] [Abstract][Full Text] [Related]
8. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.
Stein JA; Adler A; Efraim SB; Maor M
Cancer; 1976 Sep; 38(3):1171-87. PubMed ID: 953963
[TBL] [Abstract][Full Text] [Related]
9. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
[TBL] [Abstract][Full Text] [Related]
10. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
[TBL] [Abstract][Full Text] [Related]
11. Immunocompetence, immunodeficiency and prognosis in cancer.
Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune competence in patients with prostatic carcinoma.
Stefani SS; Menon M; Canning JR; Clark SS
J Urol; 1978 Oct; 120(4):431-4. PubMed ID: 702665
[TBL] [Abstract][Full Text] [Related]
13. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiestrogen and progestin on immune functions in breast cancer patients.
Scambia G; Panici PB; Maccio A; Castelli P; Serri F; Mantovani G; Massidda B; Iacobelli S; Del Giacco S; Mancuso S
Cancer; 1988 Jun; 61(11):2214-8. PubMed ID: 2966668
[TBL] [Abstract][Full Text] [Related]
15. [Immunocompetence of newborn calves: evaluation of the proliferative response of lymphocytes in vitro to 3 nonspecific mitogens (concanavalin A, phytohemagglutinin, pokeweed mitogen) during the 1st 3 months of life].
Person JM; Quintin-Colonna F; Barrat F; Le Garrec Y; Pilet C
Comp Immunol Microbiol Infect Dis; 1983; 6(4):345-56. PubMed ID: 6671377
[TBL] [Abstract][Full Text] [Related]
16. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
Sasaki T; Fujisaki S
Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
[TBL] [Abstract][Full Text] [Related]
17. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
Hsu MM; Lin BL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
[TBL] [Abstract][Full Text] [Related]
18. T-cell deficiency in patients with squamous cell cancer of the head and neck.
Wanebo HJ; Jun MY; Strong EW; Oettgen H
Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
[TBL] [Abstract][Full Text] [Related]
19. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
Lee YT
J Surg Oncol; 1984 Nov; 27(3):135-40. PubMed ID: 6492808
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
